METROPOLITAN LIFE INSURANCE CO/NY - Y-MABS THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 100 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,200
-19.7%
2,0550.0%0.00%0.0%
Q2 2023$13,953
+35.5%
2,0550.0%0.00%0.0%
Q1 2023$10,296
-8.0%
2,055
-10.4%
0.00%0.0%
Q4 2022$11,190
-66.3%
2,293
-0.5%
0.00%
-50.0%
Q3 2022$33,238
-4.7%
2,3050.0%0.00%0.0%
Q2 2022$34,875
+27.4%
2,3050.0%0.00%
+100.0%
Q1 2022$27,383
-82.4%
2,305
-75.9%
0.00%
-50.0%
Q4 2021$155,178
-43.2%
9,5730.0%0.00%
-50.0%
Q3 2021$273,213
-14.3%
9,573
+1.5%
0.00%0.0%
Q2 2021$318,835
+17.7%
9,433
+5.3%
0.00%0.0%
Q1 2021$270,981
-40.9%
8,961
-3.3%
0.00%
-42.9%
Q4 2020$458,661
+29.0%
9,2640.0%0.01%
+16.7%
Q3 2020$355,645
-11.1%
9,2640.0%0.01%
-14.3%
Q2 2020$400,205
+110.5%
9,264
+27.1%
0.01%
+75.0%
Q1 2020$190,165
-16.5%
7,2860.0%0.00%0.0%
Q4 2019$227,688
+19.9%
7,2860.0%0.00%
+33.3%
Q3 2019$189,873
+422.5%
7,286
+358.5%
0.00%
+200.0%
Q2 2019$36,340–1,589–0.00%–
 Download
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 216,916$6,191,0003.86%
Sofinnova Investments, Inc. 2,194,278$62,625,0003.71%
MPM BioImpact LLC 452,970$12,928,0002.00%
Soleus Capital Management, L.P. 265,700$7,583,0001.18%
ASHFORD CAPITAL MANAGEMENT INC 452,110$12,903,0001.17%
ORACLE INVESTMENT MANAGEMENT INC 315,642$9,008,0001.12%
First Light Asset Management, LLC 577,663$16,487,0001.09%
Lombard Odier Asset Management (Switzerland) SA 352,839$10,070,0000.62%
Cormorant Asset Management, LP 500,000$14,270,0000.58%
Artal Group S.A. 400,000$11,416,0000.26%
View complete list of Y-MABS THERAPEUTICS INC shareholders